| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/15/2004 | WO2004058746A1 Substituted benzodioxepins |
| 07/15/2004 | WO2004058744A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof |
| 07/15/2004 | WO2004058739A1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 07/15/2004 | WO2004058707A1 Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058679A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058353A2 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 07/15/2004 | WO2004058287A2 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/15/2004 | WO2004058271A1 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 07/15/2004 | WO2004058258A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058256A1 Pharmaceutical liquid composition containing pyridone derivative |
| 07/15/2004 | WO2004058255A1 4, 5-diarylthiazole derivatives as cb-1 ligands |
| 07/15/2004 | WO2004058244A1 The use of succinate derivative esters for the treatment of dementia |
| 07/15/2004 | WO2004058239A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058237A1 Therapeutic use of sibutramine and analogues thereof |
| 07/15/2004 | WO2004058152A2 An extended release pharmaceutical composition of phenytoin sodium |
| 07/15/2004 | WO2004058139A2 Use of istradefylline (kw-6002) for the treatment of behavioral disorders |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004043900A3 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 07/15/2004 | WO2004041245A3 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | WO2004035813A3 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 07/15/2004 | WO2004024130A3 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE |
| 07/15/2004 | WO2004014881B1 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 07/15/2004 | WO2004009026A3 Cholinergic therapy for individuals with learning disabilities |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003089608A3 Drg11-responsive (dragon) gene family |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138474 Distillation of a solution of dichloroethane mixtures with alcohols as solvents and water |
| 07/15/2004 | US20040138473 Process for the preparation of 1, 2-dichloroethane free crystals of zonisamide |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138460 Hydrolysis of phenylcarbamate of paroxetine in solvent |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138447 Nonhygroscopic heterocyclic amine hydrate containg compound as antidepressant formed by drying and crystals in air |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138312 use of alpha 2 adrenergic receptor-selective agonists to prevent nerve cell damage and death, such as that observed in Parkinson's disease and Alzheimer's disease |
| 07/15/2004 | US20040138305 Alpha2delta ligands for the treatment of fibromyalgia and other disorders |
| 07/15/2004 | US20040138304 Prodrugs of excitatory amino acids |
| 07/15/2004 | US20040138296 Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease |
| 07/15/2004 | US20040138293 Pharmaceutical composition made of cannabis extracts |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 07/15/2004 | US20040138281 Parkinson's and Huntington's disease; psychoses, impotence, renal or heart failure, schizophrenia |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138273 Carbocycle based inhibitors of glycogen synthase kinase 3 |
| 07/15/2004 | US20040138268 Aminoalkyl thiazole derivatives as KCNQ modulators |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138252 Pharmaceutical composition for therapy of interstitial cystitis |
| 07/15/2004 | US20040138238 Substituted aminopyrimidine compounds as neurokinin antagonists |
| 07/15/2004 | US20040138236 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/15/2004 | US20040138232 Psychological disorders; acylation the corresponding indol-2-one form with acylation agent |
| 07/15/2004 | US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers |
| 07/15/2004 | US20040138221 Pyrrrolo[1,2-b]pyridazine compounds and their uses |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138202 Tetracyclic azepinoindole compounds |
| 07/15/2004 | US20040138201 Prevent forming deposits of amyloid protein on nervous systems; Alzheimer's disease; Down syndrome |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138153 enzyme inhibitors; drug screening |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138130 Active modified hedgehog proteins |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040137612 Bone marrow multipotent stem cells for propagation of osteoblast, chrondrocytes, myoblasts, adipocytes, endothelial and neuronal tissues; tissue engineering |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137156 for sustained release; compressed tablets/capsules |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040136993 inducing an immunogenic response against alpha-SN |
| 07/15/2004 | US20040136922 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 07/15/2004 | US20040136914 Buccal, polar and non-polar spray containing ondansetron |
| 07/15/2004 | US20040136913 Buccal, polar and non-polar spray containing sumatriptan |
| 07/15/2004 | US20040136908 Anti-cd19 immunotoxins |
| 07/15/2004 | DE202004006157U1 Pharmaceutical or dietetic product useful for treating headache and migraine comprises a blueberry extract together with vitamins and minerals |
| 07/15/2004 | CA2511779A1 Use of istradefylline (kw-6002) for the treatment of behavioral disorders |
| 07/15/2004 | CA2511606A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | CA2511603A1 4, 5-diarylthiazole derivatives as cb-1 ligands |
| 07/15/2004 | CA2511599A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |